We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.35%
10 Year Est. Return
AUM
$871M
AUM Growth
-$69.5M
Cap. Flow
-$137M
Cap. Flow %
-15.72%
Top 10 Hldgs %
40.19%
Holding
614
New
49
Increased
59
Reduced
166
Closed
105

Top Buys

Rank Stock Value
1
TVRD
Tvardi Therapeutics
TVRD
+$1.25M
2
LNT icon
Alliant Energy
LNT
+$1.13M
3
ROKU icon
Roku
ROKU
+$787K
4
NOW icon
ServiceNow
NOW
+$662K
5
DUK icon
Duke Energy
DUK
+$545K

Top Sells

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$49.7M
2
AAPL icon
Apple
AAPL
+$3.88M
3
MSFT icon
Microsoft
MSFT
+$3.61M
4
UNH icon
UnitedHealth
UNH
+$3.12M
5
V icon
Visa
V
+$2.98M

Sector Composition

Rank Sector Weight
1 Technology 19.28%
2 Consumer Discretionary 11.65%
3 Healthcare 10.31%
4 Financials 8.18%
5 Communication Services 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPE icon
126
Expedia Group
EXPE
$36.5B
$1.42M 0.16%
8,672
+182
+2% +$31.2K
MBUU icon
127
Malibu Boats
MBUU
$548M
$1.41M 0.16%
19,239
-545
-3% -$43.4K
MRVL icon
128
Marvell Technology
MRVL
$147B
$1.41M 0.16%
24,179
HRC
129
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.4M 0.16%
12,300
SPGI icon
130
S&P Global
SPGI
$124B
$1.39M 0.16%
3,378
-1,043
-24% -$401K
NI icon
131
NiSource
NI
$21.5B
$1.38M 0.16%
56,337
+6,300
+13% +$160K
GPK icon
132
Graphic Packaging
GPK
$3.35B
$1.37M 0.16%
75,651
-25,298
-25% -$462K
NATI
133
DELISTED
National Instruments Corp
NATI
$1.35M 0.16%
31,998
-3,683
-10% -$155K
EQC
134
DELISTED
Equity Commonwealth
EQC
$1.35M 0.16%
51,547
-79,875
-61% -$2.22M
PYPL icon
135
PayPal
PYPL
$49.9B
$1.34M 0.15%
4,591
-479
-9% -$127K
ZS icon
136
Zscaler
ZS
$24.9B
$1.32M 0.15%
6,108
+1,923
+46% +$366K
DOV icon
137
Dover
DOV
$26.7B
$1.31M 0.15%
8,700
PTEN icon
138
Patterson-UTI
PTEN
$3.54B
$1.29M 0.15%
130,100
DDS icon
139
Dillards
DDS
$9.2B
$1.28M 0.15%
7,100
JYNT icon
140
The Joint Corp
JYNT
$119M
$1.26M 0.14%
14,988
CL icon
141
Colgate-Palmolive
CL
$74.8B
$1.23M 0.14%
15,129
+1,509
+11% +$123K
GILD icon
142
Gilead Sciences
GILD
$165B
$1.23M 0.14%
17,872
VNDA icon
143
Vanda Pharmaceuticals
VNDA
$304M
$1.19M 0.14%
55,400
BAH icon
144
Booz Allen Hamilton
BAH
$8.44B
$1.19M 0.14%
13,961
+31
+0.2% +$2.62K
HES
145
DELISTED
Hess
HES
$1.18M 0.14%
13,502
-2,117
-14% -$171K
OII icon
146
Oceaneering
OII
$4.64B
$1.17M 0.13%
74,800
REZI icon
147
Resideo Technologies
REZI
$5.4B
$1.16M 0.13%
38,600
BRSL
148
Brightstar Lottery PLC
BRSL
$1.9B
$1.14M 0.13%
47,700
LGND icon
149
Ligand Pharmaceuticals
LGND
$5.77B
$1.13M 0.13%
13,821
LNT icon
150
Alliant Energy
LNT
$18.6B
$1.11M 0.13%
+19,944
New +$1.13M

Similar funds

First Quadrant's Q2 2021 Portfolio in Review

As of Q2 2021, First Quadrant held 614 positions worth $871M, down 7.4% from $940M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

First Quadrant withdrew a net $137M in Q2 2021, closing 105 positions and reducing 166 holdings. Its most notable exit was Brown & Brown, an estimated $1.65M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, First Quadrant opened a new position in Tvardi Therapeutics worth $1.02M.

  • First Quadrant's largest Q2 2021 buy was Tvardi Therapeutics: 1,978 shares worth $1.02M.
  • First Quadrant added most to ServiceNow in Q2 2021, an estimated $662K increase.
  • First Quadrant's biggest Q2 2021 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $49.7M.
  • First Quadrant fully exited Brown & Brown in Q2 2021, selling an estimated $1.65M.
  • First Quadrant's ten largest holdings make up 40% of its $871M portfolio in Q2 2021.
  • First Quadrant opened 49 new positions and closed 105 in Q2 2021.
  • First Quadrant's portfolio value fell 7.4% quarter-over-quarter to $871M.

Based on First Quadrant's 13F filing for Q2 2021, filed 23 Jul 2021.